நன்மை ஆபத்து நிபுணர் வேலை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நன்மை ஆபத்து நிபுணர் வேலை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நன்மை ஆபத்து நிபுணர் வேலை Today - Breaking & Trending Today

UK regulator approves Pfizer/BioNTech vaccine for 12 to 15-year-old kids


UK regulator approves Pfizer/BioNTech vaccine for 12 to 15-year-old kids
In this file photo taken on November 17, 2020 An illustration picture shows vials with Covid-19 Vaccine stickers attached and syringes with the logo of US pharmaceutical company Pfizer and German partner BioNTech, on November 17, 2020. - Britains medicines regulator said on June 4, 2021 the Pfizer/BioNTech vaccine is safe for adolescents aged 12 to 15 after a rigorous review , following similar assessments in the EU and US.
(Photo by AFP)
London: The UK s medicines regulator on Friday approved the Pfizer/BioNTech coronavirus vaccine for 12 to 15 year olds.
The Medicines and Healthcare products Regulatory Agency (MHRA) said the decision followed a rigorous review of safety and effectiveness in the lower age groups and its conclusion is that the benefits of the vaccine far outweigh any risks. Until now, COVID-19 vaccines being administered in the UK have been approved for adults aged 16 and ....

United Kingdom , City Of , June Raine , Munir Pirmohamed , Vaccines Benefit Risk Expert Working Group , Committee On Vaccination , United Kingdom Commission On Human Medicines , A Department Of Health , Paediatric Medicines Expert Advisory Group , Regulatory Agency , National Health Service , United Kingdom Approved , Joint Committee , Professor Sir Munir Pirmohamed , Human Medicines , Medicines Expert Advisory Group , Benefit Risk Expert Working , Yellow Card , Social Care , Coronavirus Pandemic , Covid 19 Vaccine , Pfizer Biontech , ஒன்றுபட்டது கிஂக்டம் , நகரம் ஆஃப் , ஜூன் மழை , தடுப்பு மருந்துகள் நன்மை ஆபத்து நிபுணர் வேலை குழு ,

Coronavirus vaccine - weekly summary of Yellow Card reporting


© Crown copyright 2021
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: [email protected].
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/coronavirus-covid-19-vaccine-adverse-reactions/coronavirus-vaccine-summary-of-yellow-card-reporting
This report covers the period 9 December 2020 to 14 March 2021.
Summary
At the time of this report, over 125,000 people across the UK have died within 28 days of a positive test for coronavirus (COVID-19). Rates of COVID-19 infection and hospitalisation remain high. ....

United Kingdom , Northern Ireland , Oxford University Astrazeneca , United Kingdom Public Health , Vaccines Safety Surveillance Methodologies Expert Working Group , Regulatory Agency , National Institute For Health Research , Clinical Practice Research Datalink , Vaccines Benefit Risk Expert Working Group , Commission On Human Medicines , Department Of Health , Temporal Association , United Kingdom Department Of Health , Office For National Statistics , Agency Of The Department Health , Yellow Card , Social Care , Human Medicines , Coronavirus Yellow Card , Kingdom Yellow Cards , Yellow Cards , National Statistics , Vaccine Analysis , Vaccine Analysis Profile , Practice Research Datalink , National Institute ,